KURA Oncology’s Stock Climbs As New Drug Development Takes Center Stage
During the current market session, Kura Oncology, Inc. (NASDAQ: KURA) is observing a significant upsurge in its stock, demonstrating a notable escalation of 8.53% to $19.02. This positive movement in KURA shares can be attributed to the recent strides made by the company in the realm of novel drug development. Today, Kura Oncology (KURA) has […]
KURA Oncology’s Stock Climbs As New Drug Development Takes Center Stage Read More »